{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:58:12Z","timestamp":1782435492613,"version":"3.54.5"},"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA232616-02"],"award-info":[{"award-number":["R01 CA232616-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI147060-01A1"],"award-info":[{"award-number":["R01 AI147060-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA229673-01A1"],"award-info":[{"award-number":["R01 CA229673-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA022443-42"],"award-info":[{"award-number":["P01 CA022443-42"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Humans are infected with two types of EBV (Type 1 (T1) and Type 2 (T2)) that differ substantially in their EBNA2 and EBNA 3A\/B\/C latency proteins and have different phenotypes in B cells. T1 EBV transforms B cells more efficiently than T2 EBV <jats:italic>in vitro<\/jats:italic>, and T2 EBV-infected B cells are more lytic. We previously showed that both increased NFATc1\/c2 activity, and an NFAT-binding motif within the BZLF1 immediate-early promoter variant (Zp-V3) contained in all T2 strains, contribute to lytic infection in T2 EBV-infected B cells. Here we compare cellular and viral gene expression in early-passage lymphoblastoid cell lines (LCLs) infected with either T1 or T2 EBV strains. Using bulk RNA-seq, we show that T2 LCLs are readily distinguishable from T1 LCLs, with approximately 600 differentially expressed cellular genes. Gene Set Enrichment Analysis (GSEA) suggests that T2 LCLs have increased B-cell receptor (BCR) signaling, NFAT activation, and enhanced expression of epithelial-mesenchymal-transition-associated genes. T2 LCLs also have decreased RNA and protein expression of a cellular gene required for survival of T1 LCLs, IRF4. In addition to its essential role in plasma cell differentiation, IRF4 decreases BCR signaling. Knock-down of IRF4 in a T1 LCL (infected with the Zp-V3-containing Akata strain) induced lytic reactivation whereas over-expression of IRF4 in Burkitt lymphoma cells inhibited both NFATc1 and NFATc2 expression and lytic EBV reactivation. Single-cell RNA-seq confirmed that T2 LCLs have many more lytic cells compared to T1 LCLs and showed that lytically infected cells have both increased NFATc1, and decreased IRF4, compared to latently infected cells. These studies reveal numerous differences in cellular gene expression in B cells infected with T1 versus T2 EBV and suggest that decreased IRF4 contributes to both the latent and lytic phenotypes in cells with T2 EBV.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010453","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T18:01:44Z","timestamp":1650996104000},"page":"e1010453","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-8126","authenticated-orcid":true,"given":"Jillian A.","family":"Bristol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-4860","authenticated-orcid":true,"given":"Joshua","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Eichelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Casco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-1355","authenticated-orcid":true,"given":"Scott E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-0568","authenticated-orcid":true,"given":"James C.","family":"Romero-Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-5300","authenticated-orcid":true,"given":"Dana C.","family":"Baiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-2192","authenticated-orcid":true,"given":"Jenny E.","family":"Gumperz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-1126","authenticated-orcid":true,"given":"Huy Q.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-6526","authenticated-orcid":true,"given":"Shannon C.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"ppat.1010453.ref001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010","volume":"9","author":"G Khan","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"ppat.1010453.ref002","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"LS Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"ppat.1010453.ref003","first-page":"1898","volume-title":"Epstein-Barr Virus\/Replication and Epstein-Barr Virus","author":"E Kieff","year":"2013","edition":"6"},{"key":"ppat.1010453.ref004","doi-asserted-by":"crossref","first-page":"E1824","DOI":"10.3390\/microorganisms8111824","article-title":"Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis.","volume":"8","author":"Q Rosemarie","year":"2020","journal-title":"Microorganisms."},{"key":"ppat.1010453.ref005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein-Barr virus","volume":"26","author":"SC Kenney","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"ppat.1010453.ref006","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo","volume":"79","author":"LL Laichalk","year":"2005","journal-title":"J Virol"},{"key":"ppat.1010453.ref007","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1128\/JVI.01055-07","article-title":"Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter","volume":"81","author":"CC Sun","year":"2007","journal-title":"J Virol"},{"key":"ppat.1010453.ref008","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1128\/JVI.00154-07","article-title":"X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D","volume":"81","author":"PM Bhende","year":"2007","journal-title":"J Virol"},{"key":"ppat.1010453.ref009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.2910330106","article-title":"Cross-linking of cell surface immunoglobulins induces epstein-barr virus in burkitt lymphoma lines","volume":"33","author":"K. Takada","year":"1984","journal-title":"Int J Cancer"},{"key":"ppat.1010453.ref010","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.02781-14","article-title":"Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters","volume":"89","author":"JA Reusch","year":"2015","journal-title":"J Virol"},{"issue":"Pt 11","key":"ppat.1010453.ref011","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1099\/0022-1317-68-11-2853","article-title":"New type B isolates of Epstein-Barr virus from Burkitt\u2019s lymphoma and from normal individuals in endemic areas","volume":"68","author":"LS Young","year":"1987","journal-title":"J Gen Virol"},{"key":"ppat.1010453.ref012","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection","volume":"89","author":"AL Palser","year":"2015","journal-title":"J Virol"},{"key":"ppat.1010453.ref013","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00375-17","article-title":"Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.","volume":"91","author":"S Correia","year":"2017","journal-title":"J Virol."},{"key":"ppat.1010453.ref014","article-title":"Sequence variation of Epstein-Barr virus: viral types, geography, codon usage and diseases","author":"S Correia","year":"2018","journal-title":"J Virol"},{"key":"ppat.1010453.ref015","first-page":"875","article-title":"Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt\u2019s lymphomas","volume":"6","author":"WL Goldschmidts","year":"1992","journal-title":"Leukemia"},{"key":"ppat.1010453.ref016","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/infdis\/162.3.642","article-title":"Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects","volume":"162","author":"TB Sculley","year":"1990","journal-title":"J Infect Dis"},{"key":"ppat.1010453.ref017","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(89)90829-5","article-title":"Detection of a second widespread strain of Epstein-Barr virus","volume":"2","author":"JW Sixbey","year":"1989","journal-title":"Lancet Lond Engl"},{"key":"ppat.1010453.ref018","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1128\/JVI.01000-14","article-title":"A Single Amino Acid in EBNA-2 Determines Superior B Lymphoblastoid Cell Line Growth Maintenance by Epstein-Barr Virus Type 1 EBNA-2","volume":"88","author":"S Tzellos","year":"2014","journal-title":"J Virol"},{"key":"ppat.1010453.ref019","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1128\/JVI.00223-08","article-title":"Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2","volume":"82","author":"W Lucchesi","year":"2008","journal-title":"J Virol"},{"key":"ppat.1010453.ref020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/jvi.61.5.1310-1317.1987","article-title":"Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells","volume":"61","author":"AB Rickinson","year":"1987","journal-title":"J Virol"},{"key":"ppat.1010453.ref021","doi-asserted-by":"crossref","first-page":"e1007458","DOI":"10.1371\/journal.ppat.1007458","article-title":"Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.","volume":"15","author":"R Ponnusamy","year":"2019","journal-title":"PLoS Pathog"},{"key":"ppat.1010453.ref022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/jvi.69.1.253-262.1995","article-title":"Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1","volume":"69","author":"E Johannsen","year":"1995","journal-title":"J Virol"},{"key":"ppat.1010453.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002164","article-title":"C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7.","volume":"7","author":"L Cancian","year":"2011","journal-title":"PLoS Pathog."},{"key":"ppat.1010453.ref024","doi-asserted-by":"crossref","first-page":"e1008365","DOI":"10.1371\/journal.ppat.1008365","article-title":"B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1\/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.","volume":"16","author":"JC Romero-Masters","year":"2020","journal-title":"PLoS Pathog."},{"key":"ppat.1010453.ref025","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00813-18","article-title":"Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice","volume":"92","author":"CB Coleman","year":"2018","journal-title":"J Virol"},{"key":"ppat.1010453.ref026","doi-asserted-by":"crossref","first-page":"e1007179","DOI":"10.1371\/journal.ppat.1007179","article-title":"A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.","volume":"14","author":"JA Bristol","year":"2018","journal-title":"PLOS Pathog"},{"key":"ppat.1010453.ref027","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"HI Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"ppat.1010453.ref028","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1250020","article-title":"Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-\u03baB activation","volume":"344","author":"H Shinohara","year":"2014","journal-title":"Science"},{"key":"ppat.1010453.ref029","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20100945","article-title":"NFATc1 affects mouse splenic B cell function by controlling the calcineurin\u2014NFAT signaling network","volume":"208","author":"S Bhattacharyya","year":"2011","journal-title":"J Exp Med"},{"key":"ppat.1010453.ref030","doi-asserted-by":"crossref","first-page":"565458","DOI":"10.3389\/fimmu.2020.565458","article-title":"Activated Human Memory B Lymphocytes Use CR4 (CD11c\/CD18) for Adhesion, Migration, and Proliferation.","volume":"11","author":"Z Nagy-Bal\u00f3","year":"2020","journal-title":"Front Immunol."},{"key":"ppat.1010453.ref031","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1084\/jem.174.6.1313","article-title":"Regulated expression and function of CD11c\/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c\/CD18","volume":"174","author":"AA Postigo","year":"1991","journal-title":"J Exp Med"},{"key":"ppat.1010453.ref032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-981-10-3233-2_18","article-title":"Roles of RUNX in B Cell Immortalisation","volume":"962","author":"MJ West","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"ppat.1010453.ref033","first-page":"646","article-title":"A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn","volume":"189","author":"D Barua","year":"2012","journal-title":"J Immunol Baltim Md 1950."},{"key":"ppat.1010453.ref034","first-page":"787","article-title":"CD137 promotes proliferation and survival of human B cells","volume":"184","author":"X Zhang","year":"2010","journal-title":"J Immunol Baltim Md 1950."},{"key":"ppat.1010453.ref035","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1080\/10428194.2019.1607330","article-title":"Epstein-Barr virus-encoded LMP1 induces ectopic CD137 expression on Hodgkin and Reed-Sternberg cells via the PI3K-AKT-mTOR pathway","volume":"60","author":"SP Aravinth","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"ppat.1010453.ref036","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3389\/fimmu.2018.01606","article-title":"Expression and Function of Tetraspanins and Their Interacting Partners in B Cells.","volume":"9","author":"F Zou","year":"2018","journal-title":"Front Immunol."},{"key":"ppat.1010453.ref037","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","article-title":"Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells","volume":"13","author":"J Sun","year":"2015","journal-title":"Cell Rep"},{"key":"ppat.1010453.ref038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.20160789","article-title":"The aryl hydrocarbon receptor controls cell-fate decisions in B cells","volume":"214","author":"B Vaidyanathan","year":"2017","journal-title":"J Exp Med"},{"key":"ppat.1010453.ref039","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2017.04.005","article-title":"CRISPR\/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors","volume":"21","author":"Y Ma","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ppat.1010453.ref040","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/JVI.00163-08","article-title":"Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes","volume":"82","author":"D Xu","year":"2008","journal-title":"J Virol"},{"key":"ppat.1010453.ref041","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41375-021-01178-5","article-title":"IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK","volume":"35","author":"R Maffei","year":"2021","journal-title":"Leukemia"},{"key":"ppat.1010453.ref042","doi-asserted-by":"crossref","first-page":"41081","DOI":"10.18632\/oncotarget.9596","article-title":"Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia","volume":"7","author":"V Shukla","year":"2016","journal-title":"Oncotarget"},{"key":"ppat.1010453.ref043","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2013-08-521120","article-title":"IRF4(-\/-)Vh11 mice: a novel mouse model of CLL.","volume":"122","author":"Y Zhong","year":"2013","journal-title":"Blood"},{"key":"ppat.1010453.ref044","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1182\/blood-2013-03-492769","article-title":"A role for IRF4 in the development of CLL","volume":"122","author":"V Shukla","year":"2013","journal-title":"Blood"},{"key":"ppat.1010453.ref045","doi-asserted-by":"crossref","first-page":"26430","DOI":"10.1074\/jbc.M113.475913","article-title":"Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4","volume":"288","author":"S Ma","year":"2013","journal-title":"J Biol Chem"},{"key":"ppat.1010453.ref046","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2010.01.002","article-title":"Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines","volume":"400","author":"ML Davies","year":"2010","journal-title":"Virology"},{"key":"ppat.1010453.ref047","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ebiom.2018.10.065","article-title":"Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.","volume":"37","author":"J-B Zhang","year":"2018","journal-title":"EBioMedicine."},{"key":"ppat.1010453.ref048","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/JVI.02318-15","article-title":"Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.","volume":"90","author":"I Tempera","year":"2016","journal-title":"J Virol"},{"key":"ppat.1010453.ref049","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"T Stuart","year":"2019","journal-title":"Cell"},{"key":"ppat.1010453.ref050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.173.3.763","article-title":"High levels of CD44 expression distinguish virgin from antigen-primed B cells","volume":"173","author":"RL Camp","year":"1991","journal-title":"J Exp Med"},{"key":"ppat.1010453.ref051","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1182\/blood-2011-09-378877","article-title":"BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation","volume":"119","author":"FM Wensveen","year":"2012","journal-title":"Blood"},{"key":"ppat.1010453.ref052","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","article-title":"Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4","volume":"38","author":"K Ochiai","year":"2013","journal-title":"Immunity"},{"key":"ppat.1010453.ref053","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3389\/fcell.2020.616592","article-title":"What Will B Will B: Identifying Molecular Determinants of Diverse B-Cell Fate Decisions Through Systems Biology.","volume":"8","author":"S. Mitchell","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"ppat.1010453.ref054","first-page":"382","article-title":"Comprehensive characterization of driver genes in diffuse large B cell lymphoma","volume":"20","author":"Z Fan","year":"2020","journal-title":"Oncol Lett"},{"key":"ppat.1010453.ref055","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1002\/ajh.24778","article-title":"A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation","volume":"92","author":"A Sacco","year":"2017","journal-title":"Am J Hematol"},{"key":"ppat.1010453.ref056","first-page":"e00716","article-title":"Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells","volume":"92","author":"CD Wood","year":"2018","journal-title":"J Virol"},{"key":"ppat.1010453.ref057","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/onc.2016.380","article-title":"LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required","volume":"36","author":"L Wang","year":"2017","journal-title":"Oncogene"},{"key":"ppat.1010453.ref058","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1128\/JVI.01435-13","article-title":"Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells","volume":"87","author":"L Wang","year":"2013","journal-title":"J Virol"},{"key":"ppat.1010453.ref059","doi-asserted-by":"crossref","first-page":"e1003314","DOI":"10.1371\/journal.ppat.1003314","article-title":"The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.","volume":"9","author":"S Banerjee","year":"2013","journal-title":"PLoS Pathog."},{"key":"ppat.1010453.ref060","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/JVI.02737-15","article-title":"Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.","volume":"90","author":"A Wang","year":"2015","journal-title":"J Virol"},{"key":"ppat.1010453.ref061","doi-asserted-by":"crossref","first-page":"e2001992","DOI":"10.1371\/journal.pbio.2001992","article-title":"EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency","volume":"15","author":"CT Styles","year":"2017","journal-title":"PLoS Biol"},{"key":"ppat.1010453.ref062","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1073\/pnas.1921139117","article-title":"Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis","volume":"117","author":"T Sommermann","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1010453.ref063","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ng.219","article-title":"A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia","volume":"40","author":"MC Di Bernardo","year":"2008","journal-title":"Nat Genet"},{"key":"ppat.1010453.ref064","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1099\/jgv.0.001249","article-title":"IRF4 promotes Epstein-Barr virus activation in Burkitt\u2019s lymphoma cells","volume":"100","author":"Y Gao","year":"2019","journal-title":"J Gen Virol"},{"key":"ppat.1010453.ref065","doi-asserted-by":"crossref","first-page":"26318","DOI":"10.1073\/pnas.2007946117","article-title":"Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A","volume":"117","author":"K Fish","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1010453.ref066","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1101\/gad.309583.117","article-title":"Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming","volume":"32","author":"R Li","year":"2018","journal-title":"Genes Dev"},{"key":"ppat.1010453.ref067","doi-asserted-by":"crossref","first-page":"e1005339","DOI":"10.1371\/journal.ppat.1005339","article-title":"EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-j\u03ba and EBF1.","volume":"12","author":"F Lu","year":"2016","journal-title":"PLOS Pathog."},{"key":"ppat.1010453.ref068","doi-asserted-by":"crossref","first-page":"e1006664","DOI":"10.1371\/journal.ppat.1006664","article-title":"EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.","volume":"13","author":"LV Glaser","year":"2017","journal-title":"PLoS Pathog"},{"key":"ppat.1010453.ref069","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1172\/JCI126726","article-title":"Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer","volume":"130","author":"M Xing","year":"2020","journal-title":"J Clin Invest"},{"key":"ppat.1010453.ref070","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1128\/JVI.00692-07","article-title":"ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells","volume":"81","author":"W Feng","year":"2007","journal-title":"J Virol"},{"key":"ppat.1010453.ref071","doi-asserted-by":"crossref","first-page":"e62586","DOI":"10.7554\/eLife.62586","article-title":"Single-cell RNA-seq reveals transcriptomic heterogeneity mediated by host-pathogen dynamics in lymphoblastoid cell lines","volume":"10","author":"ED SoRelle","year":"2021","journal-title":"eLife"},{"key":"ppat.1010453.ref072","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1478-811X-10-16","article-title":"NFATc1\/\u03b1A: The other Face of NFAT Factors in Lymphocytes.","volume":"10","author":"E Serfling","year":"2012","journal-title":"Cell Commun Signal CCS"},{"key":"ppat.1010453.ref073","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/v13050846","article-title":"Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus.","volume":"13","author":"S Bhaduri-McIntosh","year":"2021","journal-title":"Viruses"},{"key":"ppat.1010453.ref074","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00571929","article-title":"An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA","volume":"5","author":"K Takada","year":"1991","journal-title":"Virus Genes"},{"key":"ppat.1010453.ref075","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells","volume":"74","author":"SJ Molesworth","year":"2000","journal-title":"J Virol"},{"key":"ppat.1010453.ref076","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1084\/jem.167.6.1811","article-title":"Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt\u2019s lymphoma underlies tumor cell escape from virus-specific T cell surveillance","volume":"167","author":"CD Gregory","year":"1988","journal-title":"J Exp Med"},{"key":"ppat.1010453.ref077","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/272629a0","article-title":"A new tumour-derived transforming strain of Epstein-Barr virus","volume":"272","author":"PA Pizzo","year":"1978","journal-title":"Nature"},{"key":"ppat.1010453.ref078","volume":"12","author":"NL Toomey","journal-title":"Induction of a TRAIL mediated suicide program by interferon alpha in primary elusion lymphoma."},{"key":"ppat.1010453.ref079","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chom.2013.11.009","article-title":"Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition.","volume":"14","author":"Y-F Chiu","year":"2013","journal-title":"Cell Host Microbe."},{"key":"ppat.1010453.ref080","doi-asserted-by":"crossref","first-page":"e1007221","DOI":"10.1371\/journal.ppat.1007221","article-title":"An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.","volume":"14","author":"JC Romero-Masters","year":"2018","journal-title":"PLoS Pathog."},{"key":"ppat.1010453.ref081","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Y Liao","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ppat.1010453.ref082","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"MD Robinson","year":"2010","journal-title":"Genome Biol"},{"key":"ppat.1010453.ref083","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ppat.1010453.ref084","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"VK Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"ppat.1010453.ref085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2105-6-144","article-title":"PAGE: parametric analysis of gene set enrichment","volume":"6","author":"S-Y Kim","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"ppat.1010453.ref086","first-page":"JVI0163521","article-title":"Accurate quantification of overlapping herpesvirus transcripts from RNA-seq data","author":"A Casco","year":"2021","journal-title":"J Virol"},{"key":"ppat.1010453.ref087","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data.","volume":"32","author":"Z Gu","year":"2016","journal-title":"Bioinforma Oxf Engl"},{"key":"ppat.1010453.ref088","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Y Hao","year":"2021","journal-title":"Cell"},{"key":"ppat.1010453.ref089","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors.","volume":"8","author":"CS McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"ppat.1010453.ref090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"C Hafemeister","year":"2019","journal-title":"Genome Biol"},{"key":"ppat.1010453.ref091","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"G Finak","year":"2015","journal-title":"Genome Biol"},{"key":"ppat.1010453.ref092","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinforma Oxf Engl"},{"key":"ppat.1010453.ref093","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.75.5.2388-2399.2001","article-title":"Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies","volume":"75","author":"AL Adamson","year":"2001","journal-title":"J Virol"},{"key":"ppat.1010453.ref094","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1128\/jvi.70.12.8340-8347.1996","article-title":"A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator","volume":"70","author":"RT Sarisky","year":"1996","journal-title":"J Virol"},{"key":"ppat.1010453.ref095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"G Lu","year":"2014","journal-title":"Science"},{"key":"ppat.1010453.ref096","doi-asserted-by":"crossref","first-page":"e1005195","DOI":"10.1371\/journal.ppat.1005195","article-title":"Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.","volume":"11","author":"DM Nawandar","year":"2015","journal-title":"PLOS Pathog."}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T18:02:54Z","timestamp":1650996174000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010453"}},"subtitle":[],"editor":[{"given":"Christian","family":"Munz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":96,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010453","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]}}}